Celcuity (CELC) Total Current Liabilities (2016 - 2025)
Celcuity (CELC) posted Total Current Liabilities of $44.2 million for Q4 2025, up 13.82% on a QoQ basis from $38.8 million in Q3 2025, and up 39.18% year-over-year from $31.7 million in Q4 2024.
Celcuity (CELC) Total Current Liabilities (2016 - 2025) Analysis & Trends
Celcuity's Total Current Liabilities history runs 10 years deep, the most recent figure standing at $44.2 million for Q4 2025.
- Quarterly Total Current Liabilities rose 39.18% year-over-year to $44.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $44.2 million (up 39.18% YoY) and the FY2025 annual result came in at $44.2 million, up 39.18% from the prior year.
- Total Current Liabilities was $44.2 million for Q4 2025 at Celcuity, up from $38.8 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $44.2 million in Q4 2025 and bottomed at $1.2 million in Q1 2021.
- A 5-year average of $16.0 million and a median of $9.9 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2021 — Total Current Liabilities jumped 35.33% — and 2022, when it soared 203.35%.
- Celcuity's Total Current Liabilities stood at $2.5 million in 2021, then soared by 174.64% to $6.9 million in 2022, then jumped by 106.19% to $14.2 million in 2023, then surged by 123.58% to $31.7 million in 2024, then surged by 39.18% to $44.2 million in 2025.
- Business Quant data shows CELC's Total Current Liabilities at $44.2 million in Q4 2025, $38.8 million in Q3 2025, and $39.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - | 44.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 44.15 Mn |
| Sep 30, 2025 | 38.79 Mn |
| Jun 30, 2025 | 39.94 Mn |
| Mar 31, 2025 | 32.92 Mn |
| Dec 31, 2024 | 31.72 Mn |
| Sep 30, 2024 | 26.31 Mn |
| Jun 30, 2024 | 19.53 Mn |
| Mar 31, 2024 | 16.70 Mn |
| Dec 31, 2023 | 14.19 Mn |
| Sep 30, 2023 | 12.71 Mn |
| Jun 30, 2023 | 7.08 Mn |
| Mar 31, 2023 | 5.81 Mn |
| Dec 31, 2022 | 6.88 Mn |
| Sep 30, 2022 | 6.65 Mn |
| Jun 30, 2022 | 4.15 Mn |
| Mar 31, 2022 | 3.55 Mn |
| Dec 31, 2021 | 2.51 Mn |
| Sep 30, 2021 | 2.82 Mn |
| Jun 30, 2021 | 1.54 Mn |
| Mar 31, 2021 | 1.17 Mn |